Multiple Myeloma | Specialty

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Dr. Raje Discusses Investigational Treatment Strategies in Multiple Myeloma

December 1st 2018

Dr. Desai Discusses Advances in Treatment for Patients With AML

December 1st 2018

OncLive News Network On Location: In San Diego Monday, December 3

December 1st 2018

OncLive News Network On Location: In San Diego Sunday, December 2

December 1st 2018

OncLive News Network On Location: In San Diego Saturday, December 1

December 1st 2018

Dr. Jagannath on the Importance of Biology in Multiple Myeloma

November 29th 2018

Sundar Jagannath, MD, director of the Multiple Myeloma program and professor of medicine at the Tisch Cancer Institute, Mount Sinai Health System, discusses the importance of biology in multiple myeloma.

Myeloma Expert Previews 2018 ASH Abstracts

November 28th 2018

Ahead of the 2018 ASH Annual Meeting, multiple myeloma experts Sundar Jagannath, MBBS, selected the most pivotal abstracts in their field.

Current and Prospective Therapies Are Improving Outcomes in Relapsed Multiple Myeloma

November 24th 2018

During an OncLive Peer Exchange®, a panel of experts on multiple myeloma discussed new agents and combinations that are improving the care of patients with relapsed multiple myeloma and reviewed strategies for treating these patients when they develop drug resistance.

Unmet Needs and Final Thoughts on Myeloma

November 22nd 2018

Emerging Immunotherapy for Multiple Myeloma

November 22nd 2018

Emerging Therapies for Multiple Myeloma

November 22nd 2018

Selinexor Data in Myeloma and Personal Experience

November 22nd 2018

Selinexor Dose, Efficacy, and Adverse Effects

November 22nd 2018

Emerging Therapies: SINE inhibitor & the STORM trial

November 22nd 2018

Monoclonal Antibody, Triplet Therapy & Transplant Ineligible

November 22nd 2018

Relapse Therapy: Incremental Change Versus Different Regimen

November 22nd 2018

Incidence of Relapse for Myeloma and Triggers to Switch

November 22nd 2018

Defining Progression and an Approach to Management

November 22nd 2018

The Challenges of Long-Term Therapy

November 22nd 2018

The Definition and Importance of Long-Term Therapy

November 22nd 2018